Instituto Nacional de Ciencias Médicas y Nutricion Dr. Salvador Zubiran

Mexico City, Mexico City 14080

1 studies enrolling now · 6 studies all time

What they study most

Cardiovascular Diseases, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Connective Tissue Diseases, Dyslipidemia, Familial Primary Pulmonary Hypertension, Hypertension, Hypertension, Pulmonary, Lung Diseases, Lupus Erythematosus, Systemic, PAH, Pulmonary Arterial Hypertension, Pulmonary Hypertension

Studies at this site

• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients — Completed
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension — Enrolling by invitation
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP — Completed
• A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) — Completed